Viral Hepatitis
Infectious Diseases
3
Pipeline Programs
1
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Vir BiotechnologyCA - San Francisco
3 programs1
2
TobevibartPhase 31 trial
TobevibartPhase 31 trial
TobevibartPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
2030
2031
Vir BiotechnologyTobevibart
Vir BiotechnologyTobevibart
Vir BiotechnologyTobevibart
Clinical Trials (3)
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Start: Jul 2025Est. completion: Jul 2031
Phase 3Recruiting
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection
Start: Mar 2025Est. completion: May 2031
Phase 3Active Not Recruiting
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection
Start: Aug 2025Est. completion: Jul 2030
Phase 2Active Not Recruiting
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
7h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
9h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
9h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
13h ago
$179K - $237K/yr
Technician, Operations, DSP/ Technicien(ne) des opérations, DSP
Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr
HVAC Maintenance Technician
Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space